Clinical trial
Effects of Pioglitazone in Patients With Type 2 Diabetes Mellitus and Coronary Heart Disease at High Risk for Vascular Complications : A Placebo-Controlled Study
NCT00479986 is registered in ClinicalTrials.gov with IKFE Institute for Clinical Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Pioglitazone in Patients With Type 2 Diabetes Mellitus and Coronary Heart Disease at High Risk for Vascular Complications : A Placebo-Controlled Study
- Lead sponsor
- IKFE Institute for Clinical Research and Development
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- November 30, 2006
- Enrollment
- 92 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, type 2 diabetes mellitus